Research Article
NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer
Table 2
NUSAP1 and PCLAF and response to treatment.
| | NUSAP1 | PCLAF |
| OR | 0.00 | 0.01 | CI95% | 0.000 to 0.991 | 0.0009 to 0.1383 | p-value | 0.0417 | 0.0001 | Sensitivity | 0.00 | 0.13 | CI95% | 0.000 to 0.324 | 0.006412 to 0.4709 | Specificity | 0.61 | 0.06452 | CI95% | 0.438 to 0.763 | 0.01146 to 0.2072 | Positive predictive value | 0.00 | 0.03 | CI95% | 0.000 to 0.243 | 0.001710 to 0.1667 | Negative predictive value | 0.70 | 0.22 | CI95% | 0.515 to 0.842 | 0.03948 to 0.5474 | Likelihood ratio | 0.00 | 0.1336 |
|
|